×
More Charts Below
Chemours Research and Development Expenses 2013-2024 | CC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Recent Trends
Chemours research and development expenses from 2013 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Related Stocks
Company Name
Market
Cap
Air Liquide (AIQUY)
$114B
Air Products And Chemicals (APD)
$58.5B
Shin-Etsu Chemical (SHECY)
$53.3B
BASF SE (BASFY)
$42.6B
DuPont De Nemours (DD)
$25.2B
Dow (DOW)
$19.9B
LyondellBasell Industries (LYB)
$18.3B
Akzo Nobel (AKZOY)
$10B
Asahi Kasei (AHKSY)
$9.4B
Brenntag AG (BNTGY)
$9.1B
Eastman Chemical (EMN)
$8.8B
Mitsubishi Chemical Holdings (MTLHY)
$6.6B
Albemarle (ALB)
$6.2B
Arkema SA (ARKAY)
$5.3B
Tosoh (TOSCF)
$4.3B
Cabot (CBT)
$4.2B
SUMITOMO CHEMCL (SOMMY)
$3.8B
Resonac Holdings (SHWDY)
$3.3B
Avient (AVNT)
$2.9B
Johnson Matthey (JMPLY)
$2.7B
Olin (OLN)
$2.4B
Huntsman (HUN)
$2.3B
Innospec (IOSP)
$2.2B
Methanex (MEOH)
$1.8B
Tokuyama (TKYMY)
$1.1B
Stepan (SCL)
$1.1B
Tronox Holdings (TROX)
$829M
Kronos Worldwide Inc (KRO)
$791M
Oil-Dri Of America (ODC)
$633M
Koppers Holdings (KOP)
$510M